Orasure Technologies, Inc., was established in May 2000 and is incorporated under the laws of the State of Delaware. It merged two companies, STC Technologies and Epitope, and changed the situation of Epitope, moving from Oregon to Delaware. The Company's business primarily involves the development, manufacture, marketing and sale of oral liquid diagnostic products and sample collection devices using its proprietary oral fluid technology, as well as other diagnostic products including immunoassays and other in vitro diagnostic reagents. The company also manufactures and sells cryosurgical medical equipment for removal of benign skin lesions.
